Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
Cancer is the second leading cause of human death globally. PI3K/Akt/mTOR signaling is
one of the most frequently dysregulated signaling pathways observed in cancer patients that …
one of the most frequently dysregulated signaling pathways observed in cancer patients that …
Targeting mTOR for cancer therapy
H Hua, Q Kong, H Zhang, J Wang, T Luo… - Journal of hematology & …, 2019 - Springer
Mechanistic target of rapamycin (mTOR) is a protein kinase regulating cell growth, survival,
metabolism, and immunity. mTOR is usually assembled into several complexes such as …
metabolism, and immunity. mTOR is usually assembled into several complexes such as …
Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
Since 1984, when paclitaxel was approved by the FDA for the treatment of advanced
ovarian carcinoma, taxanes have been widely used as microtubule-targeting antitumor …
ovarian carcinoma, taxanes have been widely used as microtubule-targeting antitumor …
Targeting the PI3K/AKT/mTOR signaling pathway in lung cancer: an update regarding potential drugs and natural products
Lung cancer is one of the most common cancers and has a high mortality rate. Due to its
high incidence, the clinical management of the disease remains a major challenge. Several …
high incidence, the clinical management of the disease remains a major challenge. Several …
Mechanisms of cancer cell death induction by paclitaxel: an updated review
S Zhao, Y Tang, R Wang, M Najafi - Apoptosis, 2022 - Springer
Chemoresistance of cancer cells is a major problem in treating cancer. Knowledge of how
cancer cells may die or resist cancer drugs is critical to providing certain strategies to …
cancer cells may die or resist cancer drugs is critical to providing certain strategies to …
[HTML][HTML] Targeting autophagy-related protein kinases for potential therapeutic purpose
H **ang, J Zhang, C Lin, L Zhang, B Liu… - … Pharmaceutica Sinica B, 2020 - Elsevier
Autophagy, defined as a scavenging process of protein aggregates and damaged
organelles mediated by lysosomes, plays a significant role in the quality control of …
organelles mediated by lysosomes, plays a significant role in the quality control of …
Autophagy and its role in gastric cancer
Y Cao, Y Luo, J Zou, J Ouyang, Z Cai, X Zeng, H Ling… - Clinica Chimica …, 2019 - Elsevier
Autophagy, which is tightly regulated by a series of autophagy-related genes (ATGs), is a
vital intracellular homeostatic process through which defective proteins and organelles are …
vital intracellular homeostatic process through which defective proteins and organelles are …
Rationally designed rapamycin-encapsulated ZIF-8 nanosystem for overcoming chemotherapy resistance
M Xu, Y Hu, W Ding, F Li, J Lin, M Wu, J Wu, LP Wen… - Biomaterials, 2020 - Elsevier
Abstract Zeolitic imidazolate framework-8 (ZIF-8) nanoparticles are widely reported as a pH-
sensitive drug delivery carrier with high loading capacity for tumor therapy. However, the …
sensitive drug delivery carrier with high loading capacity for tumor therapy. However, the …
Targeted delivery of quercetin by nanoparticles based on chitosan sensitizing paclitaxel-resistant lung cancer cells to paclitaxel
Y Wang, H Yu, S Wang, C Gai, X Cui, Z Xu, W Li… - Materials Science and …, 2021 - Elsevier
Chemotherapy plays crucial roles in the clinical treatment of non-small cell lung cancer
(NSCLC). Nevertheless, acquired chemoresistance is a common and critical problem that …
(NSCLC). Nevertheless, acquired chemoresistance is a common and critical problem that …
MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer
M Hu, S Zhu, S **ong, X Xue… - Oncology reports, 2019 - spandidos-publications.com
Gastric carcinogenesis arises from complicated interactions among host, environmental and
bacterial factors, which cause genetic and epigenetic dysregulation of oncogenic and tumor …
bacterial factors, which cause genetic and epigenetic dysregulation of oncogenic and tumor …